Medication assisted treatment

Slides:



Advertisements
Similar presentations
MEDICATION ASSISTED ADDICTION TREATMENT: APPROPRIATE USE DAS Quarterly Provider Meeting Louis E. Baxter, Sr., M.D., FASAM Medical Director-DAS President.
Advertisements

Mady Chalk, PhD., MSW Treatment Research Institute November, 2013.
Ambulatory Withdrawal Management Greg Sutmiller MS, LPC, LADC.
XR-NTX Implementation in Los Angeles County Desirée A. Crèvecoeur-MacPhail, PhD UCLA Integrated Substance Abuse Programs Santa Monica Blvd., Suite.
Medication Assisted Treatment in Missouri Mark Stringer, Director Missouri Divisions of Alcohol and Drug Abuse & Comprehensive Psychiatric Services NASADAD.
1 1 Opportunities for Integrating Substance Use Disorder Treatment into Care Coordination Processes Darren Urada, Ph.D. UCLA Integrated Substance Abuse.
Colorado Department of Healthcare Policy and FinancingColorado Department of Healthcare Policy and Financing Improving health care access and outcomes.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
Outpatient Services Programs Workgroup: Service Provision under Laura’s Law June 11, 2014.
Kristie R. Schmiege, MPH, CCS, CADC, CPC-M Director of Substance Abuse Services Genesee County Community Mental Health May 18,
SUBSTANCE USE DISORDERS GENERAL METHODS OF TREATMENT Inpatient Detoxification and Rehabilitation Outpatient Individual, Couple, or Family Counseling Self-help.
January 25, 2011 Georgia Behavioral Health Caucus Community Care Joseph Bona, MD, MBA Chief Medical Officer DeKalb Community Service Board.
Strategic Planning 2013 CMHSAS-SJC Board Description of a Good and Modern Addictions and Mental Health Services System Affordable Care Act  Patient.
1 Mental Health and Substance Abuse Services Division Association of Substance Abuse Providers Mike Maples October 5, 2011.
Mental Health and Substance Abuse Services Joe Vesowate Assistant Commissioner.
Results of the Vivitrol Pilot in Los Angeles County Presented by: Desiree A. Crevecoeur-MacPhail, Ph.D. Research Psychologist, UCLA ISAP.
KENTUCKY YOUTH FIRST Grant Period August July
Module V: Coordinated Care BUPRENORPHINE TREATMENT: A Training For Multidisciplinary Addiction Professionals.
Understanding TASC Marc Harrington, LPC, LCASI Case Developer Region 4 TASC Robin Cuellar, CCJP, CSAC Buncombe County.
Recovery Support Services and Client Outcomes: What do the Data Tell Us? Recovery Community Services Program Grantee Meeting December 14, 2007.
An integrated approach to addressing opiate abuse in Maine Debra L. Brucker, MPA, PhD State of Maine Office of Substance Abuse October 2009.
Module V – Coordinated Care BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS.
Overview of BH Service Delivery in Cal MediConnect Coordinating Behavioral Health under Cal MediConnect October 3, 2013 PRESENTATION TO HASC – CAPG SOCAL.
Dave neilsen Deputy Director. Commitment, Knowledge and Services… The Department of Alcohol and Drug Programs (ADP) is committed to providing excellent.
Coverage and Management of Medications for Treating Substance Abuse in Health Plans Constance M. Horgan, Sc.D. Sharon Reif, Ph.D. Dominic Hodgkin, Ph.D.
Mission Our mission is to treat people whose health and quality of life are compromised by alcohol, drugs and mental health challenges. We do so through.
1 December 8, 2015 Crista M. Taylor, LCSW-C Director, Information, Planning and Development Adrienne Breidenstine, MSW Director of Opioid Overdose Prevention.
SUICIDE ATTEMPT DATA IN A SUICIDE PREVENTION PLANNING MODEL Susan E. Becker Ryan Mullins Mesa State College Prevention Planning Model Steps Establish.
Gaza, Sept Substance Abuse Research Center 1 Delivery Systems for Substance Abuse Treatment: Gaza and the West Bank (Palestine Territory) Mohammed.
TRANSDISCIPLINARY FOUNDATION II: TREATMENT KNOWLEDGE Contributor: Lori Phelps Lori L. Phelps California Association for Alcohol/Drug Educators, 2015 Chapter.
The CONTINUUM OF CARE Essential for Effective Substance Use Disorder Prevention, Treatment & Recovery Support Services.
Cleveland Municipal Drug Court: SAMHSA CSAT Adult Treatment Drug Court Grant Dr. Margaret Baughman Madison Wheeler, BS Paul Tuschman, BA Begun.
1 Center Mission Statements SAMHSA ? CSAT Improving the Health of the Nation by Bringing Effective Alcohol and Drug Treatment to Every Community CMHS Caring.
The DOT-Qualified Substance Abuse Professional (SAP) William “Reggie” Smith, MPA, CEAP, SAP.
1 Use of Pharmacotherapies by Substance Abuse Treatment Facilities November 2007 Cathie E. Alderks, PhD Substance Abuse and Mental Health Services Administration.
Medstat MercuryMD Micromedex PDR Solucient Substance abuse medications: Trends and prescribing patterns by physician specialty November 5, 2007 American.
Benjamin J. Pariser, DO RASE Physician.  This presentation will review the option of Medication Assisted Treatment as part of a comprehensive recovery.
Jessica Bass, LCSW, CAC III, Program Manager Outpatient and Offender Services Arapahoe House.
Behavioral Health – Primary Care Integration. Odyssey House Overview Established in 1971 Integrated System of Care Substance Use Disorder Treatment Psychiatric.
Older Americans Act Mental Health Provisions: Collaborative Strategies of AoA and SAMHSA American Public Health Association 2007 Annual Meeting November.
Medical Assisted Treatment
Medication Assisted Treatment
Mental and Behavioral Health Services
Addressing the Behavioral Health Needs of Cook County Residents
screening, brief intervention, and referral to treatment
Clinical Committee for DMC-ODS EQRO – September 16 Mtg
Illinois’ 1115 Behavioral Health Transformation Waiver
Drugs and Neuron Communication
Levels of Care Continuum of Care ASAM Patient Placement Criteria (PPC)
Integrating Care Through Partnerships – Missouri’s Experience
Justice Division Strategic Planning
Medication-Assisted Therapy at Coleman Profession Services
Public Substance Use Disorder Treatment for Youth in California County Behavioral Health Directors Association of California – All Members Meeting October.
Katherine Neuhausen, MD, MPH Chief Medical Officer
Medication Assisted Treatment
CSAT Taking Action: 2018 Snapshot
Developing an Effective Assisted Outpatient Treatment Program
Dr. Rathee, E. & Dr. Riedford, K.
FY18 Contract Training June 26, 2017.
West Virginia Medicaid Summit
The Success of IPS in Oklahoma
Women’s Treatment and Resources
Certified Community Behavioral Health Clinic
Vision Transformative collaboration that fosters resilient self-sustaining Recovery Communities. Mission To develop and sustain measurable solutions that.
Certified Community Behavioral Health Clinics
A Training For Multidisciplinary Addiction Professionals
Medications used in Treatment of Alcohol and Drug Use Disorders
The Judicial Branch’s Response to the Opioid Crisis
Medically assisted treatment
Can be personalized to individual group needs.
Presentation transcript:

Medication assisted treatment Dr. Andrew Cox, EDE, LPC, LCSW, CAC2, MAC Dayna Solomon, MPA T.J. BeMent, MPA, ICM Fellow

What is MAT? Medication-Assisted Treatment (MAT) is a form of pharmacotherapy and refers to any treatment for a substance use disorder that includes a pharmacologic intervention as part of a comprehensive substance abuse treatment plan with an ultimate goal of participant recovery with full social function.

Why MAT? Scientific evidence overwhelmingly shows that MAT is a critical tool in the treatment of opioid addiction and essential in fighting the opioid epidemic. Drug treatment courts can play a key role in ensuring that participants have access to this effective, evidence-based treatment.

Types of Mat drugs Three main medications used: Methadone – agonist that works by reducing or extinguishing cravings for opioids. Buprenorphine – is a partial agonist which functions similarly to methadone but has a lower maximal effect than a full agonist like methadone. Naltrexone – is an opioid antagonist which operates by blocking the effects of opioids so patients will not experience a high from using opioids.

MAT Brand-name Drugs Medications for Alcohol Dependence Naltrexone: (ReVia®, Vivitrol®, Depade ®) Disulfiram: (Antabuse®) Acamprosate: (Campral®) Medications for Opioid Dependence Methadone: Buprenorphine: (Suboxone® and Subutex®)

Administrative process Establish a need What can your team adequately handle? What can your team agree on? Design a written policy to address MAT in your court Get team, Board and Community buy in Decide, if any, what forms of MAT your team would like to implement?

Lets Get started! How to find a provider? Finding the right fit How to create a contract or MOU with chosen provider? Lets consider the costs: Evaluation of client Cost of medication Does client have insurance? Does insurance make a difference?

Funding Insurance that can play a part in MAT VA clinics Private Insurance Medicaid/Medicare Federal Grants (SAMHSA, BYRNE JAG, BJA) DATE Funds CACJ Funds Other Sources

mat Drug court protocols Identification of appropriate candidates Educational counseling of medication Training of team on what MAT is and is not Participant monitoring Appropriate drug testing Side effects review Review for possible misuses of medication

mat medical provider protocols Legitimate medical provider Communication between medical provider and coordinator and treatment provider Educational counseling of medication side effects and medical follow-up on side effects, if necessary Veto power of medical provider to end Tx

Cacj vivitrol pilot project

CACJ vivitrol Pilot project protocols

Does it work in a drug court Does it work in a drug court? Experience within the Muscogee County Adult Drug Court The Muscogee County Drug Court implemented MAT as an integral part of the court’s treatment mission in October, 2016 The court’s efforts to implement MAT treatment within the participant population is an on-going process The MAT population is small compared to the court’s other participant populations

Muscogee County Adult drug court mat experience Muscogee County Drug Court MAT Statistics (October 1, 2016-August 31, 2017) Age Characteristics Age Number/Percentage 18-29 1 17 % 30-39 3 50 % 40-49 2 33 % Gender Male 4 Female 2

Muscogee County Adult drug court mat experience MAT Participant Characteristics (continued) Educational Level Less than high school 2 Some high school 1 GED 2 College 1 Ethnicity Caucasian 100 % Marital Status Single 3 Married 2 Divorced 1

Muscogee County Adult drug court mat experience MAT Participant Characteristics (continued) Current employment Unemployed 4 Employed 1 Social Security/disabled 1 Military Experience None 100 % Primary Diagnosis 304.00 Opioid Use Disorder 100 % Mental Health Related Diagnosis Depression-related 2 (33%)

Muscogee County Adult drug court mat experience MAT Participant Characteristics (continued) Substance Use History 10 years or less usage 3 20 years plus usage 3 Intravenous Use 4 Current Drug Court Treatment Level Program Type ASAM Level Number of Participants Residential III.3 1 Intensive Outpatient II.1 4 Termination NA 1

Muscogee County Adult drug court mat experience MAT Participant Characteristics (continued) Assessment Scores TCU Drug Screen V results Level of Service Inventory-Revised Results average score=9 average score=31 interpretation=severe Interpretation=high medium Positive Drug Screens Number Percentage 34 32 % Number of Program Sanctions male 16 female 11

Muscogee County Adult drug court mat experience Participants with Opioid Related Substance Misuse with No MAT Treatment – Statistics (October 1, 2016-August 31, 2017) Age Characteristics Age Number/Percent 18-29 8 33 % 30-39 9 38 % 40-49 5 21% Over 50 2 8 % Gender male 6 female 18

Muscogee County Adult drug court mat experience Participants with Opioid Related Substance Misuse with No MAT Treatment Characteristics (continued) Educational Level Some high school 7 High school graduate 3 GED 4 College 10 Ethnicity Caucasian 23 Asian 1 Marital Status Single 11 Married 5 Divorced 8

Muscogee County Adult drug court mat experience Participants with Opioid Related Substance Misuse with No MAT Treatment Characteristics (continued) Current employment Unemployed 11 Disabled 3 Employed 9 Homemaker 1 Military Experience None 100 %

Muscogee County Adult drug court mat experience Participants with Opioid Related Substance Misuse with No MAT Treatment Characteristics (continued Primary Diagnosis 304.00 Opioid Use Disorder 100 % Mental Health Related Diagnosis Depression-related 6 Bipolar -related 2 Anxiety-related 4 Personality disorder 1

Muscogee County Adult drug court mat experience Participants with Opioid Related Substance Misuse with No MAT Treatment Characteristics (continued) Substance Use History 10 years or less usage 30 % 10-20 years usage 55 % Over 20 years usage 15 % Intravenous Use 65 %

Muscogee county adult drug court mat experience Participants with Opioid Related Substance Misuse with No MAT Treatment Characteristics (continued) Current Drug Court Treatment Level Program Type ASAM Level Number of Participants Residential III.3 3 Intensive Outpatient II.1 11 Termination NA 2 RSAT/PDC 3 Warrant Status 1 Program Graduate 4

Muscogee County Adult drug court mat experience Participants with Opioid Related Substance Misuse with No MAT Treatment Characteristics (continued) Assessment Scores TCU Drug Screen V results Level of Service Inventory-Revised Results average score=8 average score=26 interpretation=severe Interpretation=high medium Positive Drug Screens Number Percentage 287 16 % Number of Program Sanctions male 21 female 43

Closing REmarks